Make Real-Time, Real-World Data Work for You: How to Accelerate Clinical Trials and Enhance Market Access
Sponsored by InterSystems
Wednesday, Oct. 14, 2020 | 11:00 a.m. - 12:00 p.m. EDT
Location: Your office or conference room (no need to travel!)
Data acquisition, data management and analytics provide the business and clinical insights you need for breakthroughs at every stage of your drug’s life cycle.
Access to real-world data (RWD) is essential to improving trial recruitment, clinical operations and post-market surveillance. Yet few drugmakers have mastered its access and use.
When successfully put into practice, RWD can improve drug development. Utilizing primary and secondary data sources to achieve comprehensive longitudinal patient records leads to more robust research studies, better value-based care and improved outcomes.
Jim Coutcher, senior director/principal, global head of enriched studies, real world solutions, IQVIA, Matt Stannard, life sciences adviser, InterSystems and Qi Li, MD, physician executive, InterSystems will explain how to leverage RWD and improve your clinical trials and market access. In this free webinar, they’ll share examples and use case studies to provide an in-the-trenches perspective.
- Approaches to rapid site selection, cohort identification and patient recruitment
- How to leverage comprehensive, longitudinal patient health records to improve clinical research, health economics and outcomes research (HEOR), and market access
- Explore where the industry is headed with topics including siteless randomized clinical trials (RCTs), artificial cohorts for comparator arms and the role of RWD in artificial intelligence (AI)
Accelerate your clinical trials and improve market access with RWD. Start with this free webinar.
Who Will Benefit:
- Clinical trial managers/directors
- Clinical research managers/directors
- Health economics and outcomes research professionals
- Research and development professionals
- Commercial operations professionals
- Digital health solutions professionals
Meet Your Presenters:
Senior Director/Principal, Global Head of Enriched Studies, Real world solutions
Jim Coutcher is senior director/principal, global head of enriched studies, real world solutions, IQVIA. He has over 25 years’ experience in the pharmaceutical industry across all aspects of drug development and commercialization. He began his career at the bench in Pfizer’s laboratories for more than 10 years and later transitioned to the vendor side with positions in sales, business development, marketing and consulting. At GlobalData, he built, trained and supervised an international team of approximately 100 market research and database analysts to produce syndicated reports covering a wide range of therapeutic areas.
Life Sciences Advisor
Matt Stannard, life sciences advisor, InterSystems, is a drug and device development professional with more than 20 years of multinational experience spanning the many facets of discovery, development and patient access. He began his career in the laboratory, moving to patient-focused clinical development, and then leadership roles in business development and licensing. Mr. Stannard’s most recent venture was a game-changing digital health technology startup where he led business and corporate development, forging industry collaborations to help patients with unmet medical needs secure access to otherwise-inaccessible treatment options.
Qi Li, MD
Qi Li, MD, physician executive, InterSystems, oversees product innovation for the InterSystems HealthShare health informatics platform. In this role, Dr. Li shapes the global product direction to meet provider organizations’ needs around high performance, patient safety, quality improvement, and cost control. Dr. Li will also lead strategic initiatives in areas such as genomics and national healthcare informatics solutions for developing countries. He previously held product leadership roles at Harris Healthcare, Partners HealthCare and several healthcare IT companies.